Pawel Marschollek
Overview
Explore the profile of Pawel Marschollek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liszka K, Marschollek P, Przystupski D, Fraczkiewicz J, Mielcarek-Siedziuk M, Olejnik I, et al.
J Fungi (Basel)
. 2025 Jan;
11(1).
PMID: 39852457
Introduction: Posaconazole is recommended for prophylaxis in pediatric immunocompromised patients. Due to its variability in bioavailability and drug-to-drug interactions, EBMT recommends regimens based on therapeutic drug monitoring (TDM). Materials And...
2.
Mandryk M, Owoc-Lempach J, Cecot J, Zarzecki K, Piasta M, Wolska-Kolmus M, et al.
Cureus
. 2024 Sep;
16(8):e66441.
PMID: 39247025
Constitutional mismatch repair deficiency (CMMRD) syndrome, caused by biallelic mutations in mismatch repair genes, is one of the most aggressive hereditary cancer syndromes. This report presents the clinical course of...
3.
Marschollek P, Liszka K, Mielcarek-Siedziuk M, Dachowska-Kalwak I, Haze N, Panasiuk A, et al.
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062195
CD19-targeted CAR-T cell therapy has revolutionized the treatment of relapsed/refractory (r/r) pre-B acute lymphoblastic leukemia (ALL). However, it can be associated with acute toxicities related to immune activation, particularly cytokine...
4.
Marschollek P, Liszka K, Mielcarek-Siedziuk M, Rybka B, Ryczan-Krawczyk R, Panasiuk A, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36428483
The optimal bridging therapy before CAR-T cell infusion in pediatric relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r BCP-ALL) still remains an open question. The administration of blinatumomab prior...
5.
Szmit Z, Fraczkiewicz J, Salamonowicz-Bodzioch M, Krol A, Ussowicz M, Mielcarek-Siedziuk M, et al.
J Clin Med
. 2022 Sep;
11(17).
PMID: 36079123
Hematopoietic stem cell transplantation (HSCT) is a curative therapy for an increasing number of nonmalignant indications. Its use is restricted by severe transplant-related complications, including CMV infection; despite various prophylactic...
6.
Liszka K, Marschollek P, Gul K, Musial J, Chaber R, Miskiewicz-Bujna J, et al.
Transplant Proc
. 2021 May;
53(8):2498-2501.
PMID: 34053771
The coronavirus disease 2019 pandemic has made us adjust our standards and cope with unpredictable circumstances affecting the whole world, including the medical field. A 2-year-old boy diagnosed with X-linked...
7.
Rasala J, Marschollek P, Marschollek K, Ciszewska A, Zwolinska D, Musial K
Adv Clin Exp Med
. 2020 Dec;
29(11):1299-1304.
PMID: 33269815
Background: Kidney diseases are the main causative factors of secondary hypertension (HTN) in children. Although primary HTN is less common in the pediatric population, its increasing prevalence, especially among teenagers,...
8.
Pokryszko-Dragan A, Marschollek K, Chojko A, Karasek M, Kardys A, Marschollek P, et al.
Adv Clin Exp Med
. 2020 Apr;
29(4):469-473.
PMID: 32343889
Background: The effect multiple sclerosis (MS) has on the social functioning and integration of patients has been recently considered as an important factor of the disease. Objectives: To assess social...
9.
Janczak D, Bakowski W, Bakowska K, Marschollek K, Marschollek P, Malinowski M, et al.
J Coll Physicians Surg Pak
. 2019 Oct;
29(11):1078-1082.
PMID: 31659966
Objective: To assess the type and frequency of early postoperative complications in patients after open surgical infrarenal aneurysms repair and determination of their risk factors. Study Design: An observational study...
10.
Marschollek P, Bakowska K, Bakowski W, Marschollek K, Tarkowski R
J Cancer Educ
. 2018 Feb;
34(2):375-380.
PMID: 29399734
The way that bad news is disclosed to a cancer patient has a crucial impact on physician-patient cooperation and trust. Consensus-based guidelines provide widely accepted tools for disclosing unfavorable information....